However, bombesin receptors include three subtypes (BB1, BB2 and BB3) [65], with BB2 (formerly known as GRPR) being the specific receptor for the gastrin-releasing peptide (GRP) and a very promising targeting vector for the diagnosis and therapy of PC and BC [60]. The gene discussed is GRPR; the disease is breast cancer.